Status:
COMPLETED
Ceftobiprole in Hospital Acquired Pneumonia
Lead Sponsor:
Basilea Pharmaceutica
Conditions:
Pneumonia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug \[form\] of ceftobiprole) referred to as ceftobiprole versus a comparator in the tre...
Detailed Description
Ceftobiprole medocaril (the water-soluble prodrug \[form\] of ceftobiprole), referred to as ceftobiprole is a cephalosporin antibiotic with anti-MRSA (Methicillin-Resistant Staphylococcus Aureus) acti...
Eligibility Criteria
Inclusion
- Patients suffering from nosocomial pneumonia or ventilator-associated pneumonia
- Female patients must be postmenopausal for at least 1 year, surgically sterile, or practicing an effective method of birth control, before entry and throughout the study, and have a negative serum or urine pregnancy test at the screening
Exclusion
- Known or suspected hypersensitivity to any related antibiotic medications
- Any known or suspected condition or concurrent treatment that would be contraindicated by the prescribing information
- Treatment with any investigational drug within 30 days before enrollment
- Prior enrollment to this study
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
781 Patients enrolled
Trial Details
Trial ID
NCT00210964
Start Date
April 1 2005
End Date
May 1 2007
Last Update
September 3 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.